Vascular dementia is caused by reduced blood flow to the brain, which damages and eventually kills brain cells. It accounts for about 20% of all dementia cases, making it the second most common form after Alzheimer’s disease. The damage can happen suddenly, after a major stroke, or silently over years as tiny blood vessels in the brain narrow and stiffen. In both cases, brain tissue that doesn’t get enough oxygen and nutrients begins to break down, and the cognitive abilities that depended on those regions decline.
How Reduced Blood Flow Damages the Brain
The core problem in vascular dementia is chronic low blood flow to the brain, a state called cerebral hypoperfusion. When brain tissue is starved of oxygen, a destructive chain reaction begins. The cells lining blood vessels shift from a calm, protective state to an inflamed, clot-prone one. They stop producing enough of the signaling molecules that keep vessels relaxed and open, while pumping out more of the compounds that constrict them. Blood flow drops further.
One of the most damaging consequences is the breakdown of the blood-brain barrier, the tightly sealed wall of cells that normally keeps harmful substances in the bloodstream from reaching brain tissue. When this barrier fails, blood proteins like albumin and fibrinogen leak into the brain. Albumin triggers inflammation in surrounding support cells, while fibrinogen deposits interfere with the brain’s ability to repair the protective insulation around nerve fibers.
Meanwhile, the oxygen-starved tissue generates a flood of unstable molecules called free radicals. These attack cell membranes, proteins, and DNA, compounding the damage. The brain’s immune cells, which normally help with cleanup and repair, get locked into a persistent inflammatory state, releasing toxic chemicals that kill the cells responsible for insulating nerve fibers. As that insulation breaks down, the communication lines between brain regions slow and eventually fail. The areas hit hardest are deep in the brain, in the white matter tracts that connect different regions. This is why processing speed, attention, and executive function (planning, organizing, problem-solving) are typically the first abilities to decline.
Stroke: The Most Recognized Trigger
A stroke, whether caused by a blood clot blocking an artery or a bleed in the brain, is the single most dramatic cause of vascular dementia. The 30-year risk of developing dementia after a stroke is about 11.5%, with the danger highest in the first year. After that initial window, the elevated risk persists for decades, though at a lower level.
Not all strokes affect cognition equally. A single large stroke in a critical area, such as the thalamus or the junction of the temporal and parietal lobes, can cause immediate and significant cognitive problems. But vascular dementia can also develop after multiple smaller strokes, each one chipping away at brain function in a stepwise pattern. A person might seem stable for months, then suddenly worsen after another event. This pattern of abrupt declines followed by plateaus is one of the hallmarks that distinguishes vascular dementia from Alzheimer’s, which tends to progress more gradually.
Small Vessel Disease: The Silent Cause
Large strokes get the most attention, but disease in the brain’s smallest blood vessels is actually a more common pathway to vascular dementia. These tiny arteries and capillaries supply the deep structures of the brain. When they stiffen, narrow, or leak, they produce two types of damage visible on brain scans: lacunar infarcts (small areas of dead tissue) and white matter hyperintensities (patches of damaged insulation around nerve fibers).
Small infarcts originating from diseased small vessels contribute more to dementia risk than infarcts from large vessel blockages. The risk of cognitive impairment climbs significantly when a person has more than two lacunar infarcts outside the brainstem, or even just one or two in critical locations combined with widespread white matter damage. White matter hyperintensities primarily erode processing speed and executive function, and their impact depends on both their size and location. Scattered, punctate spots may cause no noticeable symptoms. Large, confluent areas of damage are the ones that drive cognitive decline.
What makes small vessel disease particularly dangerous is that it often progresses without obvious symptoms. There’s no sudden weakness or speech difficulty to prompt a trip to the emergency room. Instead, a person may notice gradually worsening difficulty with concentration, planning, or walking, sometimes dismissed as normal aging for years before the cumulative damage becomes undeniable.
When Vascular Damage Combines With Alzheimer’s
Pure vascular dementia, with no other brain pathology present, is actually less common than many people assume. Autopsy studies show that the combination of Alzheimer’s disease and cerebrovascular damage is the most frequent finding in dementia cases, present in roughly 30 to 40% of all people with dementia. This “mixed dementia” is more common than either condition appearing alone.
The two pathologies appear to amplify each other. Vascular damage can lower the threshold at which Alzheimer’s-related brain changes produce noticeable symptoms, and Alzheimer’s pathology may make the brain more vulnerable to the effects of reduced blood flow. For the person experiencing it, this means the clinical picture can be a blend: the gradual memory loss typical of Alzheimer’s alongside the attention and processing speed problems more characteristic of vascular damage.
Key Risk Factors
The risk factors for vascular dementia overlap heavily with those for heart disease and stroke, which makes sense given that the underlying problem is blood vessel damage.
- High blood pressure is the single most significant modifiable risk factor. The Honolulu-Asia Aging Study, which followed over 3,700 men for 25 years, found a strong link between high blood pressure in midlife (around ages 45 to 68) and vascular dementia in later life, particularly when blood pressure exceeded 160/95 mmHg. Another study of nearly 9,000 people found elevated risk at the 140/95 threshold. The key takeaway is that blood pressure in your 40s and 50s has consequences for your brain decades later.
- Diabetes damages small blood vessels throughout the body, including the brain, and accelerates the stiffening and narrowing that drives small vessel disease.
- High cholesterol contributes to the buildup of fatty deposits in blood vessel walls, restricting flow. Cholesterol-lowering medications may reduce vascular dementia risk by up to 30%, though the evidence is stronger in some populations than others.
- Smoking damages the lining of blood vessels and promotes clot formation.
- Atrial fibrillation and other heart rhythm disorders can send small clots to the brain, causing silent strokes that accumulate over time.
Age is the strongest non-modifiable risk factor. Men tend to develop vascular dementia at slightly higher rates at younger ages, partly because they experience strokes and heart disease earlier. Women over 85, however, have higher rates, driven in part by longer lifespans and the fact that diabetes, obesity, and hypertension carry a proportionally greater vascular dementia risk in women than in men.
A Rare Genetic Form: CADASIL
Most vascular dementia results from the lifestyle and medical risk factors described above, but a small number of cases are caused by inherited conditions. The most common hereditary form is CADASIL, caused by a mutation in the Notch3 gene. This mutation damages the smooth muscle cells in small blood vessel walls, leading to progressive narrowing and blockage.
CADASIL typically announces itself with migraine headaches with aura, often beginning in a person’s 20s or 30s. Over the following decades, recurrent small strokes lead to progressive cognitive decline, mood changes including depression and apathy, and difficulty walking. By age 65, most people with the mutation will have significant cognitive impairment or dementia. Because it’s inherited in a dominant pattern, each child of an affected parent has a 50% chance of carrying the mutation.
How Vascular Dementia Is Identified
Diagnosing vascular dementia requires two things: evidence of meaningful cognitive decline and evidence that cerebrovascular disease is the likely cause. Clinicians look for a characteristic cognitive profile. Unlike Alzheimer’s, where memory loss is usually the earliest and most prominent feature, vascular dementia tends to first affect processing speed, attention, and executive function. A person might struggle to plan a meal, follow a conversation with multiple speakers, or switch between tasks long before their memory noticeably fails.
The clinical picture also matters. A diagnosis is more likely when cognitive decline clearly follows a stroke, when there are physical signs of stroke (weakness on one side, visual field loss), or when a person develops the gradual onset pattern of small vessel disease: slowing cognition, a shuffling gait with small steps, urinary urgency, and personality changes like apathy or emotional outbursts without clear triggers.
Brain imaging with MRI plays a central role. Doctors look for evidence of past strokes, lacunar infarcts, and white matter damage. White matter hyperintensities are graded on the Fazekas scale from 0 (none) to 3 (large, confluent areas extending deep into the brain). Higher scores correlate with greater cognitive decline and increased frailty. A single large vessel infarct may be enough to explain mild cognitive problems, while two or more are generally needed to account for full dementia.
Reducing Your Risk
Because vascular dementia is driven by blood vessel damage, the most effective prevention strategies are the same ones that protect your heart. Controlling blood pressure in midlife is the highest-impact intervention. The research consistently shows that what happens to your blood vessels in your 40s and 50s shapes your brain health in your 70s and 80s. Managing diabetes, staying physically active, not smoking, and treating atrial fibrillation all reduce the cumulative vascular injury that leads to cognitive decline.
Cholesterol management also plays a role. A large meta-analysis found that people who used cholesterol-lowering medications had a meaningful reduction in vascular dementia risk, with some analyses showing up to a 30% lower risk and others showing a more modest 11 to 14% reduction depending on the study design. The protective effect was strongest in Asian populations studied so far, and results varied across regions, suggesting that the benefit may interact with other genetic or dietary factors.
Once vascular dementia has developed, the damage to brain tissue cannot be reversed. Treatment focuses on aggressively managing vascular risk factors to prevent further strokes and slow progression. This makes early identification of risk factors, years or even decades before cognitive symptoms appear, the most powerful tool available.